Loading news...
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) announced that the US Food and Drug Administration (FDA) will initiate review of its investigational seasonal influenza...
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) reported fourth quarter 2025 results that exceeded Wall Street expectations, sending its shares up about 11% on Friday....
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) shares fell almost 6% after the drugmaker announced that the US Food and Drug Administration’s (FDA) Center for...
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) said it expects 2025 revenue of approximately $1.9 billion, about $100 million above the midpoint of its previously...
Tamboran Resources Corporation (ASX:TBN, NYSE:TBN, OTC:TBNRL) has moved a step closer to consolidating full ownership of Falcon Oil & Gas Australia Ltd...
Orthocell Ltd (ASX:OCC, OTC:ORHHF) has delivered record quarterly revenue of $3.2 million for the quarter ended December 31, 2025, supported by ongoing...
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) on Monday reiterated its 2025 revenue guidance of $1.6 billion to $2 billion and outlined its pipeline milestones for...
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) has been awarded a ‘Hold’ rating and $30 price target, implying limited upside, from Jefferies analysts in their...
U.S. Global Investors (NASDAQ:GROW) announced that it will maintain its monthly dividend payments, with $0.0075 per share scheduled for January through...
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) stock fell sharply on the news that the Food and Drug Administration (FDA) plans to implement stricter approval...